Finario Blog

Capex Confidential: Pharma & Biotech

INSIDER PERSPECTIVES FOR CAPITAL INVESTMENT STAKEHOLDERS Regulatory scrutiny. Scientific breakthroughs. Market saturation in once-lucrative therapeutic areas. Few industries experience change at the velocity pharma and biotech do, and in 2026,

Read More »

Capex Confidential: Food & Beverage

INSIDER PERSPECTIVES FOR CAPITAL INVESTMENT STAKEHOLDERS Capex Confidential: Food & Beverage Inflation. Product personalization. And of course, AI. These are just some of the forces food and beverage leaders are

Read More »